Table 3.
Characteristics of Voluntary Reporting System Adverse Events (Type and Harm Codes)
| Event Type | N (total n=21) | |
|---|---|---|
| Falls | 6 | |
| Skin/Tissue | 1 | |
| Medication/IV | 8 | |
| *ifosfamide, methotrexate, potassium/potassium chloride, busulfan, carboplatin, etoposide/etoposdie phosphate, mesna, dextrose 5%, 0.45% NaCl, Voriconazole, fenofibrate/fenofirbrate micronized, famotidine, prednisone | ||
| Blood Product/Transfusion | 4 | |
| Harm Code | Definition | N (total n=21) |
| A | Circumstances or events that have the capacity to cause error | 4 |
| B | An error that did not reach the patient | 1 |
| C | An error that reached the patient but did not cause harm | 8 |
| D | An error that reached the patient and required monitoring or intervention to confirm that it resulted in no harm to the patient | 2 |
| E | Temporary harm to the patient and required intervention | 6 |
| F | Temporary harm to the patient and required initial or prolonged hospitalization | 0 |
| G | Permanent patient harm | 0 |
| H | Intervention required to sustain life | 0 |
| I | Patient death | 0 |
medications listed in event descriptions submitted to the Voluntary Safety Reporting System